CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology

PRESS RELEASE                                                                         CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based…

error: Content is protected !!